Association of the novel single-nucleotide polymorphism which increases oxidized low-density lipoprotein levels with cerebrovascular disease events.
Mäkelä KM, Traylor M, Oksala N, Kleber ME, Seppälä I, Lyytikäinen LP, Hernesniemi JA, Kähönen M, Bevan S, Rothwell PM, Sudlow C, Dichgans M; Wellcome Trust Case Control Consortium 2 (WTCCC2); Delgado G, Grammer TB, Scharnagl H, Markus HS, März W, Lehtimäki T.
Mäkelä KM, et al. Among authors: kahonen m.
Atherosclerosis. 2014 May;234(1):214-7. doi: 10.1016/j.atherosclerosis.2014.03.002. Epub 2014 Mar 14.
Atherosclerosis. 2014.
PMID: 24681816